HOME >> BIOLOGY >> NEWS
Screening chest x-ray detects early-stage lung cancers at high rates, study results show

Almost half of lung cancers detected by a chest x-ray were early-stage cancers, according to baseline results of a large, randomized clinical trial that is testing the efficacy of a chest x-ray as a screening test for lung cancer. The study results are published in the December 21 issue of the Journal of the National Cancer Institute.

Lung cancer causes one million deaths worldwide every year. When patients begin to experience symptoms of lung cancer, the cancers are often advanced and treatment is rarely successful; 90% of newly diagnosed lung cancer patients die within 2 years of diagnosis.

In 1992, The National Cancer Institute launched the still-ongoing Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial to evaluate screening tests for each of the four cancers. The PLCO Cancer Screening Trial is the largest trial ever conducted in the United States. The 155,000 men and women enrolled in the study were asked about past and present smoking habits, medical history of themselves and their families, and personal characteristics. For the lung cancer portion of the trial, participants were randomly assigned to a control group or to a screening group that received a single-view, posterioranterior chest x-ray.

According to the baseline results of the 77,465 patients in the screening group, reported by Martin M. Oken, M.D., of the Hubert H. Humphrey Cancer Center in Robbinsdale, Minn., and colleagues from the PLCO Project Team, 5991 (8.9%) participants had a test result that was suspicious for cancer, and after further follow-up and medical tests, 126 participants were diagnosed with lung cancer. Forty-four percent of the cancers found were diagnosed as stage I cancers. Chest x-ray detected 6.3 lung cancers per 1000 current smokers, 4.9 lung cancers per 1000 former smokers who had smoked in the past 15 years, 1.1 lung cancers per 1000 former smokers who had not smoked within the past 15 years, and 0.4 lung cancers per 1
'"/>

Contact: Ariel Whitworth
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
20-Dec-2005


Page: 1 2

Related biology news :

1. Screening for fragile skin
2. Screening approach leads to discovery of gene linked to breast cancer
3. Screening for complex genetic interactions
4. Screening blood for West Nile virus
5. NIH awards $11.9 M to The Burnham Institute to establish the San Diego Chemical Screening Center
6. Screening for genetic disorders: Need to avoid anxiety
7. Manchester University helps with pharaoh DNA analysis
8. University of Manchester researchers reveal clues to new genes behind rheumatoid arthritis
9. Manchester researcher wins Libyan award
10. 3M Manchester research center to develop vital new science
11. Manchester to spearhead 8.3 million particle physics project

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... ... Phase II contract awarded by the Joint Science & Technology Office—Chemical and Biological ... is to develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess ...
(Date:7/18/2020)... ... July 16, 2020 , ... ... the effectiveness of the Invictus Medical Neoasis™ active noise control device to attenuate ... reported that the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators ...
(Date:7/10/2020)... , ... July 09, 2020 , ... Today CJ BIO ... which will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, ... Umami Advantage will be live on Monday, July 13, 2020 at11:00 AM (CDT) during ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... ... leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... have entered into a strategic partnership whereby Catalent will provide support for the ...
(Date:7/18/2020)... ... ... After research model surgery and catheter implantation, the long journey of catheter maintenance ... a successful study, while protecting and accessing the catheter or device post-surgery is often ... Envigo in a live webinar on Wednesday, August 5, 2020 ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Institute of Technology (MIT) has expanded the company’s exclusive license to include ... into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. ...
(Date:7/1/2020)... , ... June 29, 2020 , ... ... to date growth of 40% in 2020, despite many obstacles created as a ... aims to increase revenue for its partnered medical practices and medical manufacturers by ...
Breaking Biology Technology:
Cached News: